ArticleBasic & clinical pharmacology & toxicology2022

Use of chlorprothixene and the risk of diabetes and major adverse cardiovascular events: A nationwide cohort study.

Mikkel Højlund et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.